Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001171843-23-006596
Filing Date
2023-11-01
Accepted
2023-11-01 16:27:14
Documents
1
Group Members
HARSAUL FOUNDATIONORBIT CO-INVEST A-1 LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A (AMENDMENT NO. 2) sc13da_110123.htm SC 13D/A 70684
  Complete submission text file 0001171843-23-006596.txt   72425
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Subject) CIK: 0001739426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90830 | Film No.: 231368636
SIC: 2834 Pharmaceutical Preparations

Mailing Address KARAISKAKI 6 CITY HOUSE LIMASSOL G4 3032
Business Address KARAISKAKI 6 CITY HOUSE LIMASSOL G4 3032 35725555000
Altchem Ltd (Filed by) CIK: 0001752864 (see all company filings)

EIN.: 000000000 | State of Incorp.: G4 | Fiscal Year End: 1231
Type: SC 13D/A